Stockscreener 앱 받기
291.01
2.07%
-6.16
시간 외 거래:
291.01
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Bio-Rad Receives MicroVal Validation for Two EZ-Check Listeria Testing Kits - Quality Assurance & Food Safety
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Limited Upside Amid a Competitive Landscape - DirectorsTalk Interviews
BIO - Finviz
Bio-Rad receives MicroVal validation for EZ-Check™ Listeria testing kits - News-Medical
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN
Bio Rad Laboratories Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
In Vitro Diagnostic (IVD) Quality Control Market Overview, Key - openPR.com
(BIO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BioRad Listeria Test Kits Receive MicroVal Certification - Food Safety Magazine
Bio-Rad receives microVal validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Bio-Rad (BIO) Q1 2026 Earnings Transcript - AOL.com
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential - DirectorsTalk Interviews
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching - 富途牛牛
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ - Moomoo
A Look at Bio-Rad Laboratories Inc (BIO) After 4.2% Gain -- GF V - GuruFocus
[144] BIO-RAD LABORATORIES, INC. SEC Filing - Stock Titan
Bio-Rad Laboratories stock (US09062X1037): sector focus as Elliott stake and price gains keep NYSE l - AD HOC NEWS
Form 144 BIO-RAD LABORATORIES For: 28 May By Investing.com - Investing.com South Africa
Bio-Rad’s valuation may be hard to justify as revenue growth lags industry forecasts. Optimistic investor sentiment could reverse if growth fails to improve, potentially putting pressure on the stock. - Moomoo
Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)? - Yahoo Finance
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside - DirectorsTalk Interviews
Is It Time To Reassess Bio-Rad Laboratories (BIO) After Its Recent 16% Weekly Surge? - Sahm
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B - TradingView
(BIO) Risk Channels and Responsive Allocation - Stock Traders Daily
Elliott Targets Bio-Rad After 70% Stock Collapse - GuruFocus
Dow Jones Top Company Headlines at 1 AM ET: Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - Moomoo
Research Alert: CFRA Maintains Sell Rating On Shares Of Bio-rad Laboratories Inc. - Moomoo
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN
Bio-Rad cuts 2026 outlook as Amgen lifts forecast - MSN
Bio Rad Laboratories Stock Surges 11% on Reports of Activist Elliott Investment Management Stake - TIKR.com
BIO: Digital PCR growth and quality controls drive performance amid regional and market headwinds - TradingView
BIO: Digital PCR and quality controls drive growth, with margin expansion and efficiency in focus - TradingView
How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership - Sahm
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday - Sahm
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories - Sahm
Bio-Rad Laboratories (BIO) Stock Soars 13% on Elliott Management Investment News - GuruFocus
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 13.8% Rally? GF Value Says Undervalued - GuruFocus
Why Elliott sees hidden billions inside Bio-Rad Laboratories - MSN
Bio-Rad (BIO) Sees Significant Stock Surge - GuruFocus
Bio-Rad rallies 13.9% as activist stake speculation lifts shares - Quiver Quantitative
BIO Stock Pops As Elliott Targets Turnaround And RBC Sees Upside - timothysykes.com
BIO Stock Jumps As Elliott Activist Stake Meets Bullish RBC Call - StocksToTrade
Nvidia Earnings Could Decide Whether the AI Trade Still Holds - Investing.com
Research Alert: Bio-rad Laboratories Rallies On Wsj Report Of Elliott Management Stake - Moomoo
Bio-Rad (BIO) Sees 10.5% Surge in Stock Value - GuruFocus
Why Is Bio-Rad Laboratories Stock Trending Now - Kalkine Media
Elliott Builds Big Position In Bio-Rad | The Wall Street Journalnewspaper - Magzter
Macy's, Dominion Energy, Bio-Rad Laboratories - TradingView
1.63%
자본화:
|
볼륨(24시간):